Two Weeks of HIIT May Boost Surgical Fitness in Adults Over 65
A completed UK trial tested whether a short HIIT program could rapidly improve cardiorespiratory fitness in older adults before elective surgery.
Summary
Older adults are increasingly turned away from elective surgery because age-related fitness decline raises their risk of complications. This completed trial from the University of Nottingham explored whether just two weeks of high-intensity interval training could meaningfully improve cardiorespiratory fitness in healthy adults aged 65 to 85. The study enrolled 10 participants and investigated whether a brief, structured HIIT program could serve as a rapid prehabilitation tool — boosting surgical readiness for older patients who might otherwise be denied care. The concept is compelling: if a short exercise intervention can lift VO2 max or related metrics enough to clear surgical thresholds, it could dramatically expand access to life-improving procedures for an aging population. Results from this pilot study have not been publicly reported in peer-reviewed literature yet.
Detailed Summary
Access to elective surgery declines sharply after age 65, not because older adults need it less, but because clinicians judge their cardiovascular fitness too poor to safely tolerate the physiological stress of an operation. This creates a troubling paradox: the people who most need surgical care are the ones most often denied it. Finding a way to rapidly improve surgical fitness in older adults could have significant public health implications.
Researchers at the University of Nottingham designed a pilot trial to test whether two weeks of high-intensity interval training could meaningfully improve cardiorespiratory fitness in healthy adults aged 65 to 85. HIIT — alternating short bursts of near-maximal effort with recovery periods — is known to produce rapid cardiovascular adaptations and has been shown to improve VO2 max more efficiently than moderate continuous exercise, even in older populations.
The trial enrolled 10 participants and was completed by December 2018. It targeted a condition-specific outcome: cardiorespiratory fitness, likely measured via VO2 max or related parameters that directly inform surgical risk stratification. No results have been published in a peer-reviewed journal at the time of this summary, so the actual findings, magnitude of effect, and safety profile remain unknown from public data.
The clinical implications, if the intervention proves effective, are substantial. A two-week prehabilitation window is realistic in many surgical scheduling contexts. Even modest gains in VO2 max can shift patients from high-risk to acceptable-risk categories, potentially reopening access to joint replacements, cardiac procedures, and cancer surgeries that improve quality of life.
Caveats are significant. The sample size of 10 is extremely small, limiting statistical power and generalizability. The phase is listed as NA, confirming this is a feasibility or pilot study rather than a powered efficacy trial. Broader replication in larger, more diverse cohorts will be essential before clinical adoption.
Key Findings
- Two weeks of HIIT was tested as a prehabilitation tool to boost surgical fitness in adults aged 65–85.
- Age-related fitness decline is a primary reason older adults are denied elective surgical procedures.
- HIIT is known to rapidly improve VO2 max, a key metric used in surgical risk assessment.
- This pilot trial enrolled only 10 participants; results have not yet been published in peer-reviewed form.
- Short exercise interventions before surgery could expand access to care for high-need older populations.
Methodology
This was a completed pilot/feasibility trial (Phase NA) conducted at the University of Nottingham, enrolling 10 healthy adults aged 65–85. The intervention was a two-week HIIT program targeting cardiorespiratory fitness as the primary condition of interest. No control group or blinding details are available from the abstract.
Study Limitations
The trial enrolled only 10 participants, making it severely underpowered for definitive conclusions about efficacy. Full results have not been published in a peer-reviewed journal, so findings, safety data, and effect sizes are not publicly available. This summary is based on the abstract and trial registration record only, not the full study data.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.